Table 4. Univariate and Multivariate analysis for peripheral PSMs.
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 0.975 | 0.941–1.009 | 0.144 | ||||
| BMI | 0.946 | 0.867–1.032 | 0.213 | ||||
| PSA | 1.926 | 1.179–3.145 | 0.009* | 2.029 | 1.226–3.357 | 0.006* | |
| NLR | 1.039 | 0.891–1.212 | 0.625 | ||||
| PLR | 0.996 | 0.991–1.001 | 0.13 | ||||
| LMR | 1.123 | 0.997–1.265 | 0.057 | 1.128 | 0.999–1.275 | 0.053 | |
| Prognostic nutritional index | 0.993 | 0.950–1.039 | 0.768 | ||||
| Biopsy Gleason sum (≥8 vs. <8) | 1.401 | 0.862–2.278 | 0.173 | ||||
| Perineural invasion | 1.962 | 1.173–3.281 | 0.01* | 1.934 | 1.143–3.274 | 0.014* | |
| SVI | 1.456 | 0.840–2.526 | 0.181 | ||||
| Pathologic Gleason sum (≥8 vs. <8) | 1.387 | 0.853–2.254 | 0.187 | ||||
*, statistically significant. BMI, body mass index; PSA, prostate specific antigen; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; LMR, lymphocyteto monocyte ratio; SVI, seminal vesicle invasion.